KPNC Authored Publications​, 2020 to September 2022

Hematology

25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions [PubMed Abstract] Truong, Thach-Giao

A New High Affinity Hemoglobin Variant: Hb San Francisco-KP (HBB: c.104T>C) [PubMed Abstract] Ho G; Kavecansky J; Pai AP; Tavakoli J

A prognostic information system for real-time personalized care: Lessons for embedded researchers [PubMed Abstract] Baer D; Ford MC; Herrinton L; Lieu TA; Liu L; Lyons D; Macapinlac Jr J; Needham TL; Neugebauer RS; Ng DK; Prausnitz S; Robertson WJ; Schultz KL; Stewart WK; Van_Den_Eeden S

Adding a Clinical Hemophilia Pharmacist to the Hemophilia Comprehensive Care Model Improves Health Care-Related Outcomes and Drug-Related Costs in an Integrated Health Care System [PubMed Abstract] Chamberland, Scott L; Pai, Ashok P

Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence [PubMed Abstract] Achacoso NS; Brenman LM; Fehrenbacher L; Habel L; Kushi L; Laurent CA; Lee C

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer [PubMed Abstract] Suga JM

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) [PubMed Abstract] Suga JM

Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma [PubMed Abstract] Truong T

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care [PubMed Abstract] Srivastava P

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 [PubMed Abstract] Pai AP

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients [PubMed Abstract] Pai, Ashok P

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis [PubMed Abstract] Pai AP

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients [PubMed Abstract] Pai, Ashok P

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate intensity anticoagulation in critically ill patients [PubMed Abstract] Pai AP

An upsurge of the serum free light chains as a possible missing link in tumour lysis syndrome in multiple myeloma [PubMed Abstract] Baker RJ; Jing W; Yavorkovsky LL

Anti-mullerian hormone as a serum biomarker for risk of chemotherapy-induced amenorrhea [PubMed Abstract] Fehrenbacher L

ASCO Quality Training Program: A Five-Year Review [PubMed Abstract] Karri S; Srivastava P

Association of anticoagulation use with SARS-CoV2 detection [PubMed Abstract] Dusendang JR; Ho G; Kavecansky J; Loyles JB; Pai AP; Schmittdiel JA; Tavakoli J

Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients [PubMed Abstract] Dusendang JR; Ho G; Kavecansky J; Pai AP; Schmittdiel JA; Tavakoli J

Attitudes and Perceptions of Multidisciplinary Cancer Care Clinicians Toward Telehealth and Secure Messages [PubMed Abstract] Arora A; Kolevska T; Kuehner GE; Li Y; Liu R; Lyon LL; Reed ME; Seaward SA; Sundaresan TK

Atypical "accelerated" chronic lymphocytic leukemia with abnormal lymphocyte chromatin clumping, bone involvement, and exceptional response to Imbruvica [PubMed Abstract] Yavorkovsky, Leonid L

Atypical manifestations of coronavirus disease 2019 (COVID-19)-associated autoimmune thrombotic thrombocytopenic purpura [PubMed Abstract] Cen D; Ho G; Law LY; Stenger JA

Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216) [PubMed Abstract] Harzstark AL

Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer [PubMed Abstract] Fehrenbacher, Louis; Patel, Jignesh K

Bilateral auricular lymphoplasmacytic lymphoma: barely mere coincidence [PubMed Abstract] Lee AT; Tang Z; Yavorkovsky LL

Breast Cancer Survivors' Satisfaction and Information Recall of Telehealth Survivorship Care Plan Appointments During the COVID-19 Pandemic [PubMed Abstract] Teicher S, Whitney RL, Liu R

Can Gilbert's syndrome mitigate chronic lymphocytic leukemia? [PubMed Abstract] Yavorkovsky, Leonid L

Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system [PubMed Abstract] Anshu, Prachi; Arasu, Vignesh A; Chang, Sharon B; Habel, Laurel; Kolevska, Tatjana; Kuehner, Gillian E; Kushi, Larry; Liu, Raymond; Lyon, Liisa L; Mentakis, Margaret A; Patel, Milan D; Savitz, Alison C; Seaward, Samantha A; Vuong, Brooke

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center [PubMed Abstract] Ho, Gwendolyn

Clinical Outcomes Following Regionalization of Gastric Cancer Care in a US Integrated Health Care System [PubMed Abstract] Herrinton L; Li Y; Lin TY; Shiraga S; Teh SH; Uong S

Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case Report [PubMed Abstract] Fang A; Huber RT; Morse LJ; Pan M

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia [PubMed Abstract] Vempaty HT

Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial [PubMed Abstract] Truong T

Covid-19 and Risk of Venous Thromboembolism in Ethnically Diverse Populations [PubMed Abstract] Fan DJ; Garcia EA; Go AS; Pai AP; Sung SH; Tabada GH

Creating a Blueprint of Well-Being in Oncology: An Approach for Addressing Burnout From ASCO's Clinician Well-Being Taskforce [PubMed Abstract] Srivastava P

Current Challenges in Access to Melanoma Care: A Multidisciplinary Perspective [PubMed Abstract] Truong T

Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) [PubMed Abstract] Fehrenbacher, Louis

Diffuse large B cell lymphoma: splenectomy as a cure for a spleen-limited disease [PubMed Abstract] Yavorkovsky LL

Durable Complete Remission of PD-L1 Positive NUT Carcinoma Treated With Concurrent Chemotherapy and Radiation [PubMed Abstract] Chang JS; Pan M

Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer [PubMed Abstract] Karri S

Feasibility and Value of Establishing a Community-Based Virtual Multidisciplinary Sarcoma Case Conference [PubMed Abstract] Chakedis JM; Fang A; Huber RT; Lee JD; McCormick CM; Morse LJ; Pan M; Peng PD; Schwartz CM; Sidhu M; Song JI; Yu JC; Zou Y

Feasibility and Value of Establishing a Community-Based Virtual Multidisciplinary Sarcoma Case Conference [PubMed Abstract] Chakedis JM; Fang A; Huber RT; Kim BS; Lee JD; McCormick CM; Morse LJ; Pan M; Peng PD; Schwartz CM; Sidhu M; Song JI; Yu JC; Zou Y

Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer [PubMed Abstract] Harzstark AL

Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma [PubMed Abstract] Pan M; Sidhu M; Yu JC

Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04 [PubMed Abstract] Arora, Amit

Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study [PubMed Abstract] Baer, David; Pauly, Marypat; Szpakowski, Jean-Luc; Tucker, Lue-Yen S

HRA-Based Anal Cancer Surveillance and Women [PubMed Abstract] Barnell GM; Lee SY; Shapiro L

Immune-related Adverse Effects Associated with Programmed Death-1 Inhibitor Therapy in the Treatment of Non-Small Cell Lung Cancer: Incidence, Management, and Effect on Outcomes [PubMed Abstract] Chiu TJ; Hui RL; Truong T

Impact of a Virtual Multidisciplinary Sarcoma Case Conference on Treatment Plan and Survival in a Large Integrated Healthcare System [PubMed Abstract] Fang A; Pan M; Sidhu M; Yu JC

Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, Mitigation, and Resilience [PubMed Abstract] Srivastava P

Implementation of a Multidisciplinary Expert Testicular Cancer Tumor Board Across a Large Integrated Healthcare Delivery System Via Early Case Ascertainment [PubMed Abstract] Alavi M; Altschuler A; Amsden LB; Brenman LM; De Mucha Flores AC; Harzstark AL; Herrinton L; Liu L; Presti JC; Ryken RR; Walker LC

Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California [PubMed Abstract] Dusendang JR; Liu V; Mark DG; Pai AP; Roubinian NH; Schmittdiel JA; Vinson DR

Long-term Outcomes for Ibrutinib-Rituximab and Chemoimmunotherapy in CLL: Updated Results of the E1912 Trial [PubMed Abstract] Zhang, Cong

Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma [PubMed Abstract] Baer D

Mean corpuscular volume, hematocrit and polycythemia [PubMed Abstract] Yavorkovsky LL

Measurable Residual Disease Does Not Preclude Prolonged Progression-free Survival in CLL Treated with Ibrutinib [PubMed Abstract] Zhang C

Mixed Serous and Clear Cell Adenocarcinoma of the Ovary Presenting with Symptomatic Hypercalcemia: A Case Report and Clinical Considerations [PubMed Abstract] Boland JL; Shahbazi S; Wang SE

Molecular landscape of BRAF-mutant NSCLC reveals an association between clonality and driver mutations and identifies targetable non-V600 driver mutations [PubMed Abstract] Ng CF

NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab [PubMed Abstract] Fehrenbacher L

Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task Force [PubMed Abstract] Srivastava P

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216) [PubMed Abstract] Harzstark, Andrea L

Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy [PubMed Abstract] Fehrenbacher L

Pain as Initial Presenting Symptom Is Associated With Delay to Seeking Medical Attention, Higher Risk of Relapse, and Shorter Survival in Patients With Early-Stage Extremity or Trunk Synovial Sarcoma [PubMed Abstract] Fang, Andrew; Merchant, Maqdooda; Morse, Lee J; Pan, Minggui; Song, Mee N

Patient, Family, and Clinician Perspectives on End-of-Life Care Quality Domains and Candidate Indicators for Adolescents and Young Adults With Cancer [PubMed Abstract] Altschuler A; Kolevska T; Kushi L; Schwartz CM

Patient, Family, and Clinician Perspectives on Location of Death for Adolescents and Young Adults With Cancer [PubMed Abstract] Altschuler, Andrea; Kolevska, Tatjana; Kushi, Larry; Schwartz, Corey M

Patient-Reported Outcomes Integrated Within an Electronic Medical Record in Patients With Head and Neck Cancer [PubMed Abstract] Kammerer AN; Katzel JA; Piazza-Delap LM; Stram DA

Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F [PubMed Abstract] Suga, J Marie

Pilot pragmatic randomized trial of mHealth mindfulness-based intervention for advanced cancer patients and their informal caregivers [PubMed Abstract] Aghaee S; Altschuler A; Avins AL; Greyz-Yusupov N; Kolevska T; Kubo A; Kurtovich EM; Liu R; McGinnis MK; Quesenberry CP

Possible Precipitation of Acute Coronary Syndrome with Immune Checkpoint Blockade: A Case Report [PubMed Abstract] Liu R; Manthripragada GK; Mok KY; Tavakoli J

Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer [PubMed Abstract] Suga, J Marie

Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial) [PubMed Abstract] Fehrenbacher L

Primary Care Clinicians, Cancer Survivorship, and Lifestyle Medicine [PubMed Abstract] Bodai, Balazs I; Liu, Raymond; Misquitta, Rajiv K; Nakata, Therese E; Wong, William T

Quantitative Approaches to Therapeutic Decision Making in Hepatocellular Carcinoma [PubMed Abstract] Lee SY

Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004 [PubMed Abstract] Greyz-Yusupov N

Randomized Phase II Study of PARP Inhibitor Veliparib with Modified FOLFIRI versus FOLFIRI as Second Line Treatment of Metastatic Pancreatic Cancer: SWOG S1513 [PubMed Abstract] Suga JM

Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406) [PubMed Abstract] Wang SE

Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105 [PubMed Abstract] Kuan MC

Rapid Response of a BRCA2/TP53/PTEN-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report [PubMed Abstract] Pan M

Rare Case of Mixed Phenotype Acute Leukemia Presenting as a Myeloid Sarcoma Without Leukemic Involvement [PubMed Abstract] Feldman, David S; Means, Jeffrey T; Shaw, Allison J; Vu, Khoan

Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples [PubMed Abstract] Suga JM

Regionalization of Acute Myeloid Leukemia Treatment in a Community-Based Population: Implementation and Early Results [PubMed Abstract] Baer D; Herrinton L; Law LY; Liu V; Nguyen VH; Uong S; Vempaty HT

Response to Brandt, Bednarz-Knoll, Kleinheinz et al [PubMed Abstract] Katzel JA; Silverberg MJ; Udaltsova N

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients [PubMed Abstract] Suga, J Marie

Safety of lorlatinib following alectinib-induced pneumonitis in two patients with ALK-rearranged non-small cell lung cancer: a case series [PubMed Abstract] Lei AQ

SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California [PubMed Abstract] Anantharaman A; Dusendang JR; Harzstark AL; Schmittdiel JA

Smoldering multiple myeloma 40 years later: a story of unintended disease [PubMed Abstract] Yavorkovsky LL

Synchronous Primary Pancreatic Ductal Carcinoma and Colonic Adenocarcinoma Present in a Patient With History of Skin Squamous Cell Carcinoma [PubMed Abstract] Anantharaman A; Azarm A; Lai J; Parikh PY

Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial [PubMed Abstract] Fehrenbacher L

Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic [PubMed Abstract] Arasu, Vignesh A; Chang, Sharon B; Habel, Laurel; Kolevska, Tatjana; Kuehner, Gillian E; Kushi, Larry; Liu, Raymond; Lyon, Liisa L; Mentakis, Margaret A; Patel, Milan D; Savitz, Alison C; Seaward, Samantha A; Vuong, Brooke

Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually [PubMed Abstract] Kolevska T; Liu R; Reed ME; Sundaresan TK

Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism [PubMed Abstract] Charlu MP; Pai AP; Zhu S

The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials [PubMed Abstract] Arora A

The Importance of Physician Attire-The Socks With the Bulls [PubMed Abstract] Yavorkovsky LL

Thrombotic Risk Associated with IVC Filter Placement in Patients with Heparin-Induced Thrombocytopenia [PubMed Abstract] Liu C; Rajan SS; Vempaty HT

TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer [PubMed Abstract] Achacoso NS; Alexeeff S; Arora A; Chung E; Habel L; Jiang C; Pan M; Solorzano Pinto AV; Suga JM; Sundaresan TK; Truong T; Tse P

Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study [PubMed Abstract] Fehrenbacher L

Uptake of KRAS Testing and Anti-EGFR Antibody Use for Colorectal Cancer in the VA [PubMed Abstract] Lee SY